nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—Corticosteroid Hormone Receptor Agonists—Prednisone—Crohn's disease	0.246	1	CiPCiCtD
Betamethasone—Prednisone—Crohn's disease	0.17	1	CrCtD
Betamethasone—psoriatic arthritis—Crohn's disease	0.0861	0.387	CtDrD
Betamethasone—PLA2G1B—Sulfasalazine—Crohn's disease	0.0843	0.594	CbGbCtD
Betamethasone—ankylosing spondylitis—Crohn's disease	0.0709	0.319	CtDrD
Betamethasone—ulcerative colitis—Crohn's disease	0.0652	0.294	CtDrD
Betamethasone—PTGS2—Crohn's disease	0.0537	1	CbGaD
Betamethasone—PTGS2—Balsalazide—Crohn's disease	0.0196	0.138	CbGbCtD
Betamethasone—PTGS2—Mesalazine—Crohn's disease	0.0156	0.11	CbGbCtD
Betamethasone—NR3C1—Prednisone—Crohn's disease	0.0099	0.0698	CbGbCtD
Betamethasone—PTGS2—Sulfasalazine—Crohn's disease	0.00874	0.0616	CbGbCtD
Betamethasone—Prednicarbate—Prednisone—Crohn's disease	0.00593	0.05	CrCrCtD
Betamethasone—Testolactone—Prednisone—Crohn's disease	0.00593	0.05	CrCrCtD
Betamethasone—Fluocortolone—Prednisone—Crohn's disease	0.00576	0.0486	CrCrCtD
Betamethasone—Alclometasone—Prednisone—Crohn's disease	0.0056	0.0472	CrCrCtD
Betamethasone—Amcinonide—Prednisone—Crohn's disease	0.00545	0.0459	CrCrCtD
Betamethasone—Budesonide—Prednisone—Crohn's disease	0.00545	0.0459	CrCrCtD
Betamethasone—Clobetasol propionate—Prednisone—Crohn's disease	0.00531	0.0448	CrCrCtD
Betamethasone—Diflorasone—Prednisone—Crohn's disease	0.00531	0.0448	CrCrCtD
Betamethasone—Flunisolide—Prednisone—Crohn's disease	0.00531	0.0448	CrCrCtD
Betamethasone—Fludrocortisone—Prednisone—Crohn's disease	0.00531	0.0448	CrCrCtD
Betamethasone—Desonide—Prednisone—Crohn's disease	0.00531	0.0448	CrCrCtD
Betamethasone—Paramethasone—Prednisone—Crohn's disease	0.00518	0.0436	CrCrCtD
Betamethasone—Desoximetasone—Prednisone—Crohn's disease	0.00505	0.0426	CrCrCtD
Betamethasone—Mometasone—Prednisone—Crohn's disease	0.00493	0.0416	CrCrCtD
Betamethasone—Fluprednidene Acetate—Prednisone—Crohn's disease	0.00493	0.0416	CrCrCtD
Betamethasone—Loteprednol—Prednisone—Crohn's disease	0.00493	0.0416	CrCrCtD
Betamethasone—Triamcinolone—Prednisone—Crohn's disease	0.00493	0.0416	CrCrCtD
Betamethasone—Fluorometholone—Prednisone—Crohn's disease	0.00493	0.0416	CrCrCtD
Betamethasone—Dexamethasone—Prednisone—Crohn's disease	0.00482	0.0406	CrCrCtD
Betamethasone—Rimexolone—Prednisone—Crohn's disease	0.00482	0.0406	CrCrCtD
Betamethasone—Methylprednisolone—Prednisone—Crohn's disease	0.00461	0.0389	CrCrCtD
Betamethasone—Prednisolone—Prednisone—Crohn's disease	0.00451	0.038	CrCrCtD
Betamethasone—Hydrocortisone—Prednisone—Crohn's disease	0.00433	0.0365	CrCrCtD
Betamethasone—ABCB1—Prednisone—Crohn's disease	0.0023	0.0162	CbGbCtD
Betamethasone—CYP3A4—Prednisone—Crohn's disease	0.00138	0.00973	CbGbCtD
Betamethasone—PLA2G1B—Acyl chain remodelling of PI—PLA2G4F—Crohn's disease	0.00115	0.103	CbGpPWpGaD
Betamethasone—PLA2G1B—Acyl chain remodelling of PG—PLA2G4F—Crohn's disease	0.00109	0.0984	CbGpPWpGaD
Betamethasone—PLA2G1B—Acyl chain remodelling of PS—PLA2G4F—Crohn's disease	0.00109	0.0984	CbGpPWpGaD
Betamethasone—PLA2G1B—Acyl chain remodelling of PE—PLA2G4F—Crohn's disease	0.000859	0.0773	CbGpPWpGaD
Betamethasone—PLA2G1B—Acyl chain remodelling of PC—PLA2G4F—Crohn's disease	0.000804	0.0723	CbGpPWpGaD
Betamethasone—PLA2G1B—mouth—Crohn's disease	0.000669	0.159	CbGeAlD
Betamethasone—NR3C2—Preimplantation Embryo—SOX11—Crohn's disease	0.000607	0.0546	CbGpPWpGaD
Betamethasone—PLA2G1B—epithelium—Crohn's disease	0.000389	0.0926	CbGeAlD
Betamethasone—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX4—Crohn's disease	0.000381	0.0343	CbGpPWpGaD
Betamethasone—PLA2G1B—digestive system—Crohn's disease	0.000296	0.0704	CbGeAlD
Betamethasone—PLA2G1B—Glycerophospholipid biosynthesis—PLA2G4F—Crohn's disease	0.000294	0.0264	CbGpPWpGaD
Betamethasone—Pancreatitis acute—Mesalazine—Crohn's disease	0.00022	0.00687	CcSEcCtD
Betamethasone—Acneiform eruption—Prednisone—Crohn's disease	0.000212	0.00665	CcSEcCtD
Betamethasone—Cataract subcapsular—Prednisone—Crohn's disease	0.000206	0.00643	CcSEcCtD
Betamethasone—Cognitive impairment—Prednisone—Crohn's disease	0.000206	0.00643	CcSEcCtD
Betamethasone—PLA2G1B—Phospholipid metabolism—PLA2G4F—Crohn's disease	0.000205	0.0184	CbGpPWpGaD
Betamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.000204	0.0183	CbGpPWpGaD
Betamethasone—Glucose tolerance impaired—Prednisone—Crohn's disease	0.000199	0.00623	CcSEcCtD
Betamethasone—Ulcer—Mercaptopurine—Crohn's disease	0.000198	0.00618	CcSEcCtD
Betamethasone—Drug dependence—Prednisone—Crohn's disease	0.000193	0.00605	CcSEcCtD
Betamethasone—NR3C2—smooth muscle tissue—Crohn's disease	0.000186	0.0442	CbGeAlD
Betamethasone—Benign intracranial hypertension—Prednisone—Crohn's disease	0.000183	0.00571	CcSEcCtD
Betamethasone—PGR—epithelium—Crohn's disease	0.000179	0.0426	CbGeAlD
Betamethasone—Skin atrophy—Prednisone—Crohn's disease	0.000178	0.00556	CcSEcCtD
Betamethasone—Hirsutism—Mesalazine—Crohn's disease	0.000175	0.00546	CcSEcCtD
Betamethasone—PLA2G1B—Phospholipid metabolism—MTMR3—Crohn's disease	0.000174	0.0157	CbGpPWpGaD
Betamethasone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CREM—Crohn's disease	0.000174	0.0157	CbGpPWpGaD
Betamethasone—PTGS2—gall bladder—Crohn's disease	0.000173	0.0411	CbGeAlD
Betamethasone—PGR—smooth muscle tissue—Crohn's disease	0.000173	0.0411	CbGeAlD
Betamethasone—Skin striae—Prednisone—Crohn's disease	0.000169	0.00528	CcSEcCtD
Betamethasone—Papilloedema—Prednisone—Crohn's disease	0.000169	0.00528	CcSEcCtD
Betamethasone—Thromboembolism—Prednisone—Crohn's disease	0.000169	0.00528	CcSEcCtD
Betamethasone—NR3C2—mammalian vulva—Crohn's disease	0.000167	0.0398	CbGeAlD
Betamethasone—Atrophy—Prednisone—Crohn's disease	0.000165	0.00515	CcSEcCtD
Betamethasone—Dermatitis acneiform—Prednisone—Crohn's disease	0.000157	0.00491	CcSEcCtD
Betamethasone—PTGS2—mouth—Crohn's disease	0.000154	0.0366	CbGeAlD
Betamethasone—PGR—Cellular roles of Anthrax toxin—IL18—Crohn's disease	0.000147	0.0133	CbGpPWpGaD
Betamethasone—Oesophageal ulcer—Prednisone—Crohn's disease	0.000147	0.0046	CcSEcCtD
Betamethasone—Cardiomegaly—Prednisone—Crohn's disease	0.000147	0.0046	CcSEcCtD
Betamethasone—NR3C2—digestive system—Crohn's disease	0.000147	0.0349	CbGeAlD
Betamethasone—Osteonecrosis—Prednisone—Crohn's disease	0.000144	0.00451	CcSEcCtD
Betamethasone—PGR—Nuclear signaling by ERBB4—RBX1—Crohn's disease	0.000142	0.0128	CbGpPWpGaD
Betamethasone—Hypertrichosis—Prednisone—Crohn's disease	0.000141	0.00442	CcSEcCtD
Betamethasone—Epilepsy—Prednisone—Crohn's disease	0.000141	0.00442	CcSEcCtD
Betamethasone—Blister—Mesalazine—Crohn's disease	0.000141	0.0044	CcSEcCtD
Betamethasone—Meningitis—Prednisone—Crohn's disease	0.000138	0.00433	CcSEcCtD
Betamethasone—PGR—lymphoid tissue—Crohn's disease	0.000138	0.0328	CbGeAlD
Betamethasone—Opportunistic infection—Prednisone—Crohn's disease	0.000133	0.00417	CcSEcCtD
Betamethasone—Rash erythematous—Mesalazine—Crohn's disease	0.000132	0.00414	CcSEcCtD
Betamethasone—Withdrawal symptom—Prednisone—Crohn's disease	0.000131	0.00409	CcSEcCtD
Betamethasone—Intracranial pressure increased—Prednisone—Crohn's disease	0.000128	0.00402	CcSEcCtD
Betamethasone—Leukoderma—Prednisone—Crohn's disease	0.000126	0.00395	CcSEcCtD
Betamethasone—Cognitive disorder—Prednisone—Crohn's disease	0.000124	0.00388	CcSEcCtD
Betamethasone—Impaired healing—Prednisone—Crohn's disease	0.000124	0.00388	CcSEcCtD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—Crohn's disease	0.000123	0.0111	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—PPP5C—Crohn's disease	0.000123	0.011	CbGpPWpGaD
Betamethasone—Intraocular pressure increased—Prednisone—Crohn's disease	0.000122	0.00382	CcSEcCtD
Betamethasone—Acne—Mesalazine—Crohn's disease	0.000121	0.00377	CcSEcCtD
Betamethasone—Pancreatitis acute—Prednisone—Crohn's disease	0.000116	0.00364	CcSEcCtD
Betamethasone—Amenorrhoea—Mesalazine—Crohn's disease	0.000115	0.00361	CcSEcCtD
Betamethasone—Vasculitis—Azathioprine—Crohn's disease	0.000114	0.00357	CcSEcCtD
Betamethasone—Trauma—Prednisone—Crohn's disease	0.000113	0.00353	CcSEcCtD
Betamethasone—Endophthalmitis—Prednisone—Crohn's disease	0.000113	0.00353	CcSEcCtD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CREM—Crohn's disease	0.000113	0.0101	CbGpPWpGaD
Betamethasone—Arthropathy—Mesalazine—Crohn's disease	0.000112	0.00349	CcSEcCtD
Betamethasone—Drug withdrawal syndrome—Prednisone—Crohn's disease	0.000109	0.00342	CcSEcCtD
Betamethasone—Leukocytosis—Mesalazine—Crohn's disease	0.000108	0.00338	CcSEcCtD
Betamethasone—Embolism venous—Prednisone—Crohn's disease	0.000106	0.00333	CcSEcCtD
Betamethasone—PGR—Ovarian Infertility Genes—SMAD3—Crohn's disease	0.000105	0.00942	CbGpPWpGaD
Betamethasone—NR3C1—epithelium—Crohn's disease	0.000103	0.0246	CbGeAlD
Betamethasone—Hypernatraemia—Prednisone—Crohn's disease	0.000102	0.00319	CcSEcCtD
Betamethasone—NR3C1—smooth muscle tissue—Crohn's disease	9.96e-05	0.0237	CbGeAlD
Betamethasone—NR3C1—skin of body—Crohn's disease	9.83e-05	0.0234	CbGeAlD
Betamethasone—Menstruation irregular—Prednisone—Crohn's disease	9.69e-05	0.00303	CcSEcCtD
Betamethasone—Skin exfoliation—Mesalazine—Crohn's disease	9.68e-05	0.00303	CcSEcCtD
Betamethasone—Osteoporosis—Prednisone—Crohn's disease	9.57e-05	0.00299	CcSEcCtD
Betamethasone—Neuropathy—Mesalazine—Crohn's disease	9.52e-05	0.00298	CcSEcCtD
Betamethasone—Dry eye—Mesalazine—Crohn's disease	9.37e-05	0.00293	CcSEcCtD
Betamethasone—Hirsutism—Prednisone—Crohn's disease	9.23e-05	0.00289	CcSEcCtD
Betamethasone—Multiple fractures—Prednisone—Crohn's disease	9.23e-05	0.00289	CcSEcCtD
Betamethasone—Fracture—Prednisone—Crohn's disease	9.23e-05	0.00289	CcSEcCtD
Betamethasone—Ecchymosis—Mesalazine—Crohn's disease	9.17e-05	0.00287	CcSEcCtD
Betamethasone—NR3C1—mammalian vulva—Crohn's disease	8.97e-05	0.0213	CbGeAlD
Betamethasone—PTGS2—epithelium—Crohn's disease	8.95e-05	0.0213	CbGeAlD
Betamethasone—Optic neuritis—Prednisone—Crohn's disease	8.72e-05	0.00273	CcSEcCtD
Betamethasone—PTGS2—smooth muscle tissue—Crohn's disease	8.62e-05	0.0205	CbGeAlD
Betamethasone—PTGS2—skin of body—Crohn's disease	8.51e-05	0.0202	CbGeAlD
Betamethasone—NR3C2—lymph node—Crohn's disease	8.38e-05	0.0199	CbGeAlD
Betamethasone—Embolism—Prednisone—Crohn's disease	8.36e-05	0.00262	CcSEcCtD
Betamethasone—Alopecia—Mercaptopurine—Crohn's disease	8.29e-05	0.00259	CcSEcCtD
Betamethasone—Eye pain—Mesalazine—Crohn's disease	8.16e-05	0.00255	CcSEcCtD
Betamethasone—Peptic ulcer—Prednisone—Crohn's disease	8.03e-05	0.00251	CcSEcCtD
Betamethasone—NR3C1—lymphoid tissue—Crohn's disease	7.96e-05	0.0189	CbGeAlD
Betamethasone—NR3C1—digestive system—Crohn's disease	7.87e-05	0.0187	CbGeAlD
Betamethasone—Increased appetite—Mesalazine—Crohn's disease	7.84e-05	0.00245	CcSEcCtD
Betamethasone—PGR—lymph node—Crohn's disease	7.79e-05	0.0185	CbGeAlD
Betamethasone—Dermatitis bullous—Mesalazine—Crohn's disease	7.7e-05	0.00241	CcSEcCtD
Betamethasone—PGR—Cellular roles of Anthrax toxin—IL1B—Crohn's disease	7.7e-05	0.00692	CbGpPWpGaD
Betamethasone—Suicidal ideation—Prednisone—Crohn's disease	7.65e-05	0.00239	CcSEcCtD
Betamethasone—Myopathy—Prednisone—Crohn's disease	7.65e-05	0.00239	CcSEcCtD
Betamethasone—Hepatomegaly—Prednisone—Crohn's disease	7.58e-05	0.00237	CcSEcCtD
Betamethasone—Delusion—Prednisone—Crohn's disease	7.58e-05	0.00237	CcSEcCtD
Betamethasone—Lethargy—Mesalazine—Crohn's disease	7.51e-05	0.00235	CcSEcCtD
Betamethasone—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	7.49e-05	0.00674	CbGpPWpGaD
Betamethasone—Mania—Prednisone—Crohn's disease	7.38e-05	0.00231	CcSEcCtD
Betamethasone—Osteoarthritis—Mesalazine—Crohn's disease	7.36e-05	0.0023	CcSEcCtD
Betamethasone—Affect lability—Mesalazine—Crohn's disease	7.25e-05	0.00227	CcSEcCtD
Betamethasone—Migraine—Mesalazine—Crohn's disease	7.25e-05	0.00227	CcSEcCtD
Betamethasone—Neuritis—Prednisone—Crohn's disease	7.19e-05	0.00225	CcSEcCtD
Betamethasone—Glaucoma—Prednisone—Crohn's disease	7.13e-05	0.00223	CcSEcCtD
Betamethasone—CYP19A1—lymph node—Crohn's disease	7.01e-05	0.0167	CbGeAlD
Betamethasone—PTGS2—Arachidonic acid metabolism—GPX4—Crohn's disease	6.99e-05	0.00629	CbGpPWpGaD
Betamethasone—Mood swings—Mesalazine—Crohn's disease	6.98e-05	0.00218	CcSEcCtD
Betamethasone—Fungal infection—Prednisone—Crohn's disease	6.95e-05	0.00217	CcSEcCtD
Betamethasone—PTGS2—lymphoid tissue—Crohn's disease	6.89e-05	0.0164	CbGeAlD
Betamethasone—CYP19A1—Ovarian Infertility Genes—SMAD3—Crohn's disease	6.86e-05	0.00617	CbGpPWpGaD
Betamethasone—Necrosis—Prednisone—Crohn's disease	6.84e-05	0.00214	CcSEcCtD
Betamethasone—PTGS2—digestive system—Crohn's disease	6.81e-05	0.0162	CbGeAlD
Betamethasone—Abscess—Prednisone—Crohn's disease	6.78e-05	0.00212	CcSEcCtD
Betamethasone—Dry skin—Mesalazine—Crohn's disease	6.75e-05	0.00211	CcSEcCtD
Betamethasone—Oedema—Mercaptopurine—Crohn's disease	6.67e-05	0.00209	CcSEcCtD
Betamethasone—Glycosuria—Prednisone—Crohn's disease	6.62e-05	0.00207	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	6.6e-05	0.00594	CbGpPWpGaD
Betamethasone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL3—Crohn's disease	6.56e-05	0.0059	CbGpPWpGaD
Betamethasone—Thrombocytopenia—Mercaptopurine—Crohn's disease	6.53e-05	0.00204	CcSEcCtD
Betamethasone—Petechiae—Prednisone—Crohn's disease	6.52e-05	0.00204	CcSEcCtD
Betamethasone—Acne—Prednisone—Crohn's disease	6.38e-05	0.002	CcSEcCtD
Betamethasone—Anorexia—Mercaptopurine—Crohn's disease	6.36e-05	0.00199	CcSEcCtD
Betamethasone—Contusion—Prednisone—Crohn's disease	6.15e-05	0.00192	CcSEcCtD
Betamethasone—Amenorrhoea—Prednisone—Crohn's disease	6.11e-05	0.00191	CcSEcCtD
Betamethasone—PTGS2—Overview of nanoparticle effects—CRP—Crohn's disease	6.08e-05	0.00547	CbGpPWpGaD
Betamethasone—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	6.08e-05	0.0019	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—CREM—Crohn's disease	5.98e-05	0.00538	CbGpPWpGaD
Betamethasone—CYP3A4—digestive system—Crohn's disease	5.95e-05	0.0141	CbGeAlD
Betamethasone—Arthropathy—Prednisone—Crohn's disease	5.9e-05	0.00185	CcSEcCtD
Betamethasone—Decreased appetite—Mercaptopurine—Crohn's disease	5.8e-05	0.00181	CcSEcCtD
Betamethasone—Weight increased—Mesalazine—Crohn's disease	5.79e-05	0.00181	CcSEcCtD
Betamethasone—Weight decreased—Mesalazine—Crohn's disease	5.76e-05	0.0018	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	5.76e-05	0.0018	CcSEcCtD
Betamethasone—Leukocytosis—Prednisone—Crohn's disease	5.71e-05	0.00179	CcSEcCtD
Betamethasone—Ulcer—Prednisone—Crohn's disease	5.67e-05	0.00177	CcSEcCtD
Betamethasone—Cataract—Prednisone—Crohn's disease	5.64e-05	0.00176	CcSEcCtD
Betamethasone—Haemoglobin—Azathioprine—Crohn's disease	5.62e-05	0.00176	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	5.61e-05	0.00505	CbGpPWpGaD
Betamethasone—Haemorrhage—Azathioprine—Crohn's disease	5.59e-05	0.00175	CcSEcCtD
Betamethasone—PGR—Cellular roles of Anthrax toxin—TNF—Crohn's disease	5.59e-05	0.00502	CbGpPWpGaD
Betamethasone—Neuropathy peripheral—Mesalazine—Crohn's disease	5.56e-05	0.00174	CcSEcCtD
Betamethasone—PGR—Nuclear signaling by ERBB4—JAK2—Crohn's disease	5.56e-05	0.005	CbGpPWpGaD
Betamethasone—ABCB1—epithelium—Crohn's disease	5.54e-05	0.0132	CbGeAlD
Betamethasone—Conjunctivitis—Mesalazine—Crohn's disease	5.52e-05	0.00173	CcSEcCtD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—Crohn's disease	5.5e-05	0.00495	CbGpPWpGaD
Betamethasone—Vasculitis—Prednisone—Crohn's disease	5.5e-05	0.00172	CcSEcCtD
Betamethasone—Hiccups—Prednisone—Crohn's disease	5.37e-05	0.00168	CcSEcCtD
Betamethasone—Body temperature increased—Mercaptopurine—Crohn's disease	5.27e-05	0.00165	CcSEcCtD
Betamethasone—Skin exfoliation—Prednisone—Crohn's disease	5.12e-05	0.0016	CcSEcCtD
Betamethasone—Haemoglobin—Mesalazine—Crohn's disease	5.12e-05	0.0016	CcSEcCtD
Betamethasone—Fluid retention—Prednisone—Crohn's disease	5.1e-05	0.00159	CcSEcCtD
Betamethasone—Haemorrhage—Mesalazine—Crohn's disease	5.09e-05	0.00159	CcSEcCtD
Betamethasone—Neuropathy—Prednisone—Crohn's disease	5.04e-05	0.00158	CcSEcCtD
Betamethasone—Arrhythmia—Azathioprine—Crohn's disease	5e-05	0.00156	CcSEcCtD
Betamethasone—Alopecia—Azathioprine—Crohn's disease	4.94e-05	0.00155	CcSEcCtD
Betamethasone—Oesophagitis—Prednisone—Crohn's disease	4.9e-05	0.00153	CcSEcCtD
Betamethasone—Ecchymosis—Prednisone—Crohn's disease	4.85e-05	0.00152	CcSEcCtD
Betamethasone—ABCB1—mammalian vulva—Crohn's disease	4.8e-05	0.0114	CbGeAlD
Betamethasone—PGR—Signaling by ERBB4—RBX1—Crohn's disease	4.8e-05	0.00432	CbGpPWpGaD
Betamethasone—Pulmonary oedema—Prednisone—Crohn's disease	4.78e-05	0.00149	CcSEcCtD
Betamethasone—Eye disorder—Mesalazine—Crohn's disease	4.76e-05	0.00149	CcSEcCtD
Betamethasone—Angiopathy—Mesalazine—Crohn's disease	4.62e-05	0.00145	CcSEcCtD
Betamethasone—Euphoric mood—Prednisone—Crohn's disease	4.61e-05	0.00144	CcSEcCtD
Betamethasone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Crohn's disease	4.59e-05	0.00413	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	4.59e-05	0.00413	CbGpPWpGaD
Betamethasone—Diarrhoea—Mercaptopurine—Crohn's disease	4.56e-05	0.00143	CcSEcCtD
Betamethasone—NR3C2—Gene Expression—PTRF—Crohn's disease	4.56e-05	0.0041	CbGpPWpGaD
Betamethasone—Ill-defined disorder—Azathioprine—Crohn's disease	4.52e-05	0.00141	CcSEcCtD
Betamethasone—Alopecia—Mesalazine—Crohn's disease	4.5e-05	0.00141	CcSEcCtD
Betamethasone—Thrombophlebitis—Prednisone—Crohn's disease	4.5e-05	0.00141	CcSEcCtD
Betamethasone—NR3C1—lymph node—Crohn's disease	4.49e-05	0.0107	CbGeAlD
Betamethasone—Diabetes mellitus—Prednisone—Crohn's disease	4.48e-05	0.0014	CcSEcCtD
Betamethasone—PTGS2—Selenium Micronutrient Network—GPX4—Crohn's disease	4.45e-05	0.004	CbGpPWpGaD
Betamethasone—Erythema—Mesalazine—Crohn's disease	4.43e-05	0.00139	CcSEcCtD
Betamethasone—Malaise—Azathioprine—Crohn's disease	4.39e-05	0.00137	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.37e-05	0.00393	CbGpPWpGaD
Betamethasone—Cardiac failure congestive—Prednisone—Crohn's disease	4.3e-05	0.00134	CcSEcCtD
Betamethasone—ABCB1—lymphoid tissue—Crohn's disease	4.26e-05	0.0101	CbGeAlD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—Crohn's disease	4.24e-05	0.00381	CbGpPWpGaD
Betamethasone—Vomiting—Mercaptopurine—Crohn's disease	4.24e-05	0.00133	CcSEcCtD
Betamethasone—Injury—Prednisone—Crohn's disease	4.24e-05	0.00133	CcSEcCtD
Betamethasone—ABCB1—digestive system—Crohn's disease	4.21e-05	0.01	CbGeAlD
Betamethasone—Rash—Mercaptopurine—Crohn's disease	4.2e-05	0.00132	CcSEcCtD
Betamethasone—Dermatitis—Mercaptopurine—Crohn's disease	4.2e-05	0.00131	CcSEcCtD
Betamethasone—Increased appetite—Prednisone—Crohn's disease	4.15e-05	0.0013	CcSEcCtD
Betamethasone—Myalgia—Azathioprine—Crohn's disease	4.14e-05	0.0013	CcSEcCtD
Betamethasone—Ill-defined disorder—Mesalazine—Crohn's disease	4.11e-05	0.00129	CcSEcCtD
Betamethasone—Discomfort—Azathioprine—Crohn's disease	4.09e-05	0.00128	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.09e-05	0.00368	CbGpPWpGaD
Betamethasone—Angioedema—Mesalazine—Crohn's disease	4.05e-05	0.00127	CcSEcCtD
Betamethasone—Malaise—Mesalazine—Crohn's disease	4e-05	0.00125	CcSEcCtD
Betamethasone—Cardiac failure—Prednisone—Crohn's disease	3.99e-05	0.00125	CcSEcCtD
Betamethasone—Vertigo—Mesalazine—Crohn's disease	3.98e-05	0.00125	CcSEcCtD
Betamethasone—Syncope—Mesalazine—Crohn's disease	3.98e-05	0.00124	CcSEcCtD
Betamethasone—Lethargy—Prednisone—Crohn's disease	3.98e-05	0.00124	CcSEcCtD
Betamethasone—Nausea—Mercaptopurine—Crohn's disease	3.96e-05	0.00124	CcSEcCtD
Betamethasone—PTGS2—Overview of nanoparticle effects—CXCL8—Crohn's disease	3.95e-05	0.00356	CbGpPWpGaD
Betamethasone—Infection—Azathioprine—Crohn's disease	3.95e-05	0.00123	CcSEcCtD
Betamethasone—Loss of consciousness—Mesalazine—Crohn's disease	3.9e-05	0.00122	CcSEcCtD
Betamethasone—Osteoarthritis—Prednisone—Crohn's disease	3.9e-05	0.00122	CcSEcCtD
Betamethasone—Thrombocytopenia—Azathioprine—Crohn's disease	3.89e-05	0.00122	CcSEcCtD
Betamethasone—PTGS2—lymph node—Crohn's disease	3.89e-05	0.00925	CbGeAlD
Betamethasone—CYP19A1—Metapathway biotransformation—GPX4—Crohn's disease	3.84e-05	0.00345	CbGpPWpGaD
Betamethasone—Affect lability—Prednisone—Crohn's disease	3.83e-05	0.0012	CcSEcCtD
Betamethasone—Hypertension—Mesalazine—Crohn's disease	3.83e-05	0.0012	CcSEcCtD
Betamethasone—Psychotic disorder—Prednisone—Crohn's disease	3.8e-05	0.00119	CcSEcCtD
Betamethasone—Myalgia—Mesalazine—Crohn's disease	3.78e-05	0.00118	CcSEcCtD
Betamethasone—Anxiety—Mesalazine—Crohn's disease	3.76e-05	0.00118	CcSEcCtD
Betamethasone—Discomfort—Mesalazine—Crohn's disease	3.73e-05	0.00117	CcSEcCtD
Betamethasone—Irritability—Prednisone—Crohn's disease	3.72e-05	0.00116	CcSEcCtD
Betamethasone—Hypotension—Azathioprine—Crohn's disease	3.71e-05	0.00116	CcSEcCtD
Betamethasone—Cardiac arrest—Prednisone—Crohn's disease	3.7e-05	0.00116	CcSEcCtD
Betamethasone—Mood swings—Prednisone—Crohn's disease	3.69e-05	0.00115	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Azathioprine—Crohn's disease	3.62e-05	0.00113	CcSEcCtD
Betamethasone—Anaphylactic shock—Mesalazine—Crohn's disease	3.62e-05	0.00113	CcSEcCtD
Betamethasone—Oedema—Mesalazine—Crohn's disease	3.62e-05	0.00113	CcSEcCtD
Betamethasone—Infection—Mesalazine—Crohn's disease	3.6e-05	0.00112	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	3.58e-05	0.00322	CbGpPWpGaD
Betamethasone—Dry skin—Prednisone—Crohn's disease	3.57e-05	0.00112	CcSEcCtD
Betamethasone—Shock—Mesalazine—Crohn's disease	3.56e-05	0.00111	CcSEcCtD
Betamethasone—Nervous system disorder—Mesalazine—Crohn's disease	3.55e-05	0.00111	CcSEcCtD
Betamethasone—Hypokalaemia—Prednisone—Crohn's disease	3.55e-05	0.00111	CcSEcCtD
Betamethasone—Thrombocytopenia—Mesalazine—Crohn's disease	3.54e-05	0.00111	CcSEcCtD
Betamethasone—Tachycardia—Mesalazine—Crohn's disease	3.53e-05	0.0011	CcSEcCtD
Betamethasone—PTGS2—C-MYB transcription factor network—MPO—Crohn's disease	3.52e-05	0.00316	CbGpPWpGaD
Betamethasone—Hyperhidrosis—Mesalazine—Crohn's disease	3.5e-05	0.00109	CcSEcCtD
Betamethasone—Anorexia—Mesalazine—Crohn's disease	3.45e-05	0.00108	CcSEcCtD
Betamethasone—Muscular weakness—Prednisone—Crohn's disease	3.44e-05	0.00107	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Azathioprine—Crohn's disease	3.43e-05	0.00107	CcSEcCtD
Betamethasone—PTGS2—Selenium Micronutrient Network—MPO—Crohn's disease	3.39e-05	0.00305	CbGpPWpGaD
Betamethasone—Hypotension—Mesalazine—Crohn's disease	3.38e-05	0.00106	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—IL10—Crohn's disease	3.36e-05	0.00302	CbGpPWpGaD
Betamethasone—NR3C1—Endoderm Differentiation—SMAD3—Crohn's disease	3.31e-05	0.00298	CbGpPWpGaD
Betamethasone—Musculoskeletal discomfort—Mesalazine—Crohn's disease	3.3e-05	0.00103	CcSEcCtD
Betamethasone—Sweating increased—Prednisone—Crohn's disease	3.28e-05	0.00103	CcSEcCtD
Betamethasone—Feeling abnormal—Azathioprine—Crohn's disease	3.27e-05	0.00102	CcSEcCtD
Betamethasone—Insomnia—Mesalazine—Crohn's disease	3.27e-05	0.00102	CcSEcCtD
Betamethasone—Paraesthesia—Mesalazine—Crohn's disease	3.25e-05	0.00102	CcSEcCtD
Betamethasone—Gastrointestinal pain—Azathioprine—Crohn's disease	3.25e-05	0.00102	CcSEcCtD
Betamethasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—Crohn's disease	3.23e-05	0.0029	CbGpPWpGaD
Betamethasone—Dyspepsia—Mesalazine—Crohn's disease	3.19e-05	0.000996	CcSEcCtD
Betamethasone—Decreased appetite—Mesalazine—Crohn's disease	3.15e-05	0.000984	CcSEcCtD
Betamethasone—Abdominal pain—Azathioprine—Crohn's disease	3.14e-05	0.000982	CcSEcCtD
Betamethasone—Body temperature increased—Azathioprine—Crohn's disease	3.14e-05	0.000982	CcSEcCtD
Betamethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—Crohn's disease	3.14e-05	0.00282	CbGpPWpGaD
Betamethasone—Gastrointestinal disorder—Mesalazine—Crohn's disease	3.12e-05	0.000977	CcSEcCtD
Betamethasone—Fatigue—Mesalazine—Crohn's disease	3.12e-05	0.000976	CcSEcCtD
Betamethasone—Pain—Mesalazine—Crohn's disease	3.09e-05	0.000968	CcSEcCtD
Betamethasone—Weight increased—Prednisone—Crohn's disease	3.06e-05	0.000959	CcSEcCtD
Betamethasone—Weight decreased—Prednisone—Crohn's disease	3.05e-05	0.000953	CcSEcCtD
Betamethasone—Hyperglycaemia—Prednisone—Crohn's disease	3.04e-05	0.00095	CcSEcCtD
Betamethasone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Crohn's disease	3.03e-05	0.00273	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—Crohn's disease	2.99e-05	0.00269	CbGpPWpGaD
Betamethasone—Feeling abnormal—Mesalazine—Crohn's disease	2.98e-05	0.000933	CcSEcCtD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Crohn's disease	2.97e-05	0.00267	CbGpPWpGaD
Betamethasone—Acute coronary syndrome—Prednisone—Crohn's disease	2.96e-05	0.000926	CcSEcCtD
Betamethasone—Gastrointestinal pain—Mesalazine—Crohn's disease	2.96e-05	0.000926	CcSEcCtD
Betamethasone—Neuropathy peripheral—Prednisone—Crohn's disease	2.94e-05	0.000921	CcSEcCtD
Betamethasone—Myocardial infarction—Prednisone—Crohn's disease	2.94e-05	0.000921	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—PLA2G4F—Crohn's disease	2.94e-05	0.00264	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD3—Crohn's disease	2.88e-05	0.00259	CbGpPWpGaD
Betamethasone—Urticaria—Mesalazine—Crohn's disease	2.87e-05	0.000899	CcSEcCtD
Betamethasone—Body temperature increased—Mesalazine—Crohn's disease	2.86e-05	0.000895	CcSEcCtD
Betamethasone—Abdominal pain—Mesalazine—Crohn's disease	2.86e-05	0.000895	CcSEcCtD
Betamethasone—NR3C2—Generic Transcription Pathway—UBE2D1—Crohn's disease	2.86e-05	0.00257	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—PTRF—Crohn's disease	2.78e-05	0.0025	CbGpPWpGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—TNF—Crohn's disease	2.75e-05	0.00247	CbGpPWpGaD
Betamethasone—Bradycardia—Prednisone—Crohn's disease	2.74e-05	0.000858	CcSEcCtD
Betamethasone—NR3C2—Gene Expression—ZFP36L1—Crohn's disease	2.73e-05	0.00246	CbGpPWpGaD
Betamethasone—Diarrhoea—Azathioprine—Crohn's disease	2.72e-05	0.00085	CcSEcCtD
Betamethasone—Haemoglobin—Prednisone—Crohn's disease	2.71e-05	0.000847	CcSEcCtD
Betamethasone—Haemorrhage—Prednisone—Crohn's disease	2.7e-05	0.000843	CcSEcCtD
Betamethasone—Hallucination—Prednisone—Crohn's disease	2.68e-05	0.000839	CcSEcCtD
Betamethasone—PTGS2—C-MYB transcription factor network—TAB1—Crohn's disease	2.65e-05	0.00238	CbGpPWpGaD
Betamethasone—Dizziness—Azathioprine—Crohn's disease	2.63e-05	0.000822	CcSEcCtD
Betamethasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—Crohn's disease	2.61e-05	0.00234	CbGpPWpGaD
Betamethasone—Asthenia—Mesalazine—Crohn's disease	2.6e-05	0.000812	CcSEcCtD
Betamethasone—Pruritus—Mesalazine—Crohn's disease	2.56e-05	0.000801	CcSEcCtD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	2.54e-05	0.00229	CbGpPWpGaD
Betamethasone—Vomiting—Azathioprine—Crohn's disease	2.53e-05	0.00079	CcSEcCtD
Betamethasone—Eye disorder—Prednisone—Crohn's disease	2.52e-05	0.000788	CcSEcCtD
Betamethasone—Rash—Azathioprine—Crohn's disease	2.51e-05	0.000784	CcSEcCtD
Betamethasone—Dermatitis—Azathioprine—Crohn's disease	2.5e-05	0.000783	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—MTMR3—Crohn's disease	2.5e-05	0.00225	CbGpPWpGaD
Betamethasone—Headache—Azathioprine—Crohn's disease	2.49e-05	0.000779	CcSEcCtD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—TAB1—Crohn's disease	2.48e-05	0.00223	CbGpPWpGaD
Betamethasone—Diarrhoea—Mesalazine—Crohn's disease	2.48e-05	0.000775	CcSEcCtD
Betamethasone—Angiopathy—Prednisone—Crohn's disease	2.45e-05	0.000765	CcSEcCtD
Betamethasone—ABCB1—Allograft Rejection—IL17A—Crohn's disease	2.41e-05	0.00217	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.41e-05	0.00217	CbGpPWpGaD
Betamethasone—Arrhythmia—Prednisone—Crohn's disease	2.41e-05	0.000753	CcSEcCtD
Betamethasone—ABCB1—lymph node—Crohn's disease	2.41e-05	0.00572	CbGeAlD
Betamethasone—Dizziness—Mesalazine—Crohn's disease	2.39e-05	0.000749	CcSEcCtD
Betamethasone—Alopecia—Prednisone—Crohn's disease	2.38e-05	0.000745	CcSEcCtD
Betamethasone—Nausea—Azathioprine—Crohn's disease	2.36e-05	0.000738	CcSEcCtD
Betamethasone—Erythema—Prednisone—Crohn's disease	2.35e-05	0.000734	CcSEcCtD
Betamethasone—NR3C2—Gene Expression—DNMT3A—Crohn's disease	2.32e-05	0.00209	CbGpPWpGaD
Betamethasone—Vomiting—Mesalazine—Crohn's disease	2.3e-05	0.00072	CcSEcCtD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—Crohn's disease	2.29e-05	0.00206	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—SOCS1—Crohn's disease	2.28e-05	0.00205	CbGpPWpGaD
Betamethasone—Rash—Mesalazine—Crohn's disease	2.28e-05	0.000714	CcSEcCtD
Betamethasone—Dermatitis—Mesalazine—Crohn's disease	2.28e-05	0.000713	CcSEcCtD
Betamethasone—Headache—Mesalazine—Crohn's disease	2.27e-05	0.000709	CcSEcCtD
Betamethasone—ABCB1—Allograft Rejection—IL12B—Crohn's disease	2.24e-05	0.00202	CbGpPWpGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—IL6—Crohn's disease	2.22e-05	0.002	CbGpPWpGaD
Betamethasone—Ill-defined disorder—Prednisone—Crohn's disease	2.18e-05	0.000681	CcSEcCtD
Betamethasone—Nausea—Mesalazine—Crohn's disease	2.15e-05	0.000672	CcSEcCtD
Betamethasone—Angioedema—Prednisone—Crohn's disease	2.14e-05	0.000671	CcSEcCtD
Betamethasone—Malaise—Prednisone—Crohn's disease	2.12e-05	0.000662	CcSEcCtD
Betamethasone—Vertigo—Prednisone—Crohn's disease	2.11e-05	0.000659	CcSEcCtD
Betamethasone—Syncope—Prednisone—Crohn's disease	2.1e-05	0.000658	CcSEcCtD
Betamethasone—Loss of consciousness—Prednisone—Crohn's disease	2.06e-05	0.000645	CcSEcCtD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.05e-05	0.00184	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—SMAD3—Crohn's disease	2.04e-05	0.00184	CbGpPWpGaD
Betamethasone—Convulsion—Prednisone—Crohn's disease	2.03e-05	0.000636	CcSEcCtD
Betamethasone—Hypertension—Prednisone—Crohn's disease	2.03e-05	0.000634	CcSEcCtD
Betamethasone—Myalgia—Prednisone—Crohn's disease	2e-05	0.000625	CcSEcCtD
Betamethasone—Anxiety—Prednisone—Crohn's disease	1.99e-05	0.000623	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—IFNG—Crohn's disease	1.98e-05	0.00178	CbGpPWpGaD
Betamethasone—Discomfort—Prednisone—Crohn's disease	1.97e-05	0.000617	CcSEcCtD
Betamethasone—NR3C1—Adipogenesis—SMAD3—Crohn's disease	1.97e-05	0.00177	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—TYK2—Crohn's disease	1.96e-05	0.00177	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	1.96e-05	0.00176	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—FADS1—Crohn's disease	1.95e-05	0.00175	CbGpPWpGaD
Betamethasone—Anaphylactic shock—Prednisone—Crohn's disease	1.91e-05	0.000599	CcSEcCtD
Betamethasone—Oedema—Prednisone—Crohn's disease	1.91e-05	0.000599	CcSEcCtD
Betamethasone—Infection—Prednisone—Crohn's disease	1.9e-05	0.000595	CcSEcCtD
Betamethasone—Shock—Prednisone—Crohn's disease	1.88e-05	0.000589	CcSEcCtD
Betamethasone—Nervous system disorder—Prednisone—Crohn's disease	1.88e-05	0.000587	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—JAK2—Crohn's disease	1.87e-05	0.00168	CbGpPWpGaD
Betamethasone—Tachycardia—Prednisone—Crohn's disease	1.87e-05	0.000585	CcSEcCtD
Betamethasone—Hyperhidrosis—Prednisone—Crohn's disease	1.85e-05	0.000579	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—CXCL8—Crohn's disease	1.84e-05	0.00165	CbGpPWpGaD
Betamethasone—Anorexia—Prednisone—Crohn's disease	1.83e-05	0.000571	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—GPX4—Crohn's disease	1.82e-05	0.00164	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	1.82e-05	0.00164	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	1.82e-05	0.00164	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—CRP—Crohn's disease	1.78e-05	0.0016	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL10—Crohn's disease	1.77e-05	0.00159	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—GCKR—Crohn's disease	1.76e-05	0.00158	CbGpPWpGaD
Betamethasone—Musculoskeletal discomfort—Prednisone—Crohn's disease	1.74e-05	0.000546	CcSEcCtD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—Crohn's disease	1.74e-05	0.00157	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—UBE2D1—Crohn's disease	1.74e-05	0.00157	CbGpPWpGaD
Betamethasone—Insomnia—Prednisone—Crohn's disease	1.73e-05	0.000542	CcSEcCtD
Betamethasone—Paraesthesia—Prednisone—Crohn's disease	1.72e-05	0.000538	CcSEcCtD
Betamethasone—Dyspepsia—Prednisone—Crohn's disease	1.69e-05	0.000527	CcSEcCtD
Betamethasone—Decreased appetite—Prednisone—Crohn's disease	1.66e-05	0.000521	CcSEcCtD
Betamethasone—PGR—Gene Expression—ZFP36L1—Crohn's disease	1.66e-05	0.0015	CbGpPWpGaD
Betamethasone—Fatigue—Prednisone—Crohn's disease	1.65e-05	0.000516	CcSEcCtD
Betamethasone—PTGS2—Selenium Micronutrient Network—ICAM1—Crohn's disease	1.64e-05	0.00147	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL10—Crohn's disease	1.64e-05	0.00147	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—Crohn's disease	1.62e-05	0.00146	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.61e-05	0.00145	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PTRF—Crohn's disease	1.61e-05	0.00144	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.6e-05	0.00144	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ACKR2—Crohn's disease	1.58e-05	0.00142	CbGpPWpGaD
Betamethasone—Feeling abnormal—Prednisone—Crohn's disease	1.58e-05	0.000494	CcSEcCtD
Betamethasone—NR3C2—Gene Expression—HSPA1B—Crohn's disease	1.57e-05	0.00141	CbGpPWpGaD
Betamethasone—Gastrointestinal pain—Prednisone—Crohn's disease	1.57e-05	0.00049	CcSEcCtD
Betamethasone—Urticaria—Prednisone—Crohn's disease	1.52e-05	0.000476	CcSEcCtD
Betamethasone—Abdominal pain—Prednisone—Crohn's disease	1.51e-05	0.000473	CcSEcCtD
Betamethasone—Body temperature increased—Prednisone—Crohn's disease	1.51e-05	0.000473	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—MLN—Crohn's disease	1.5e-05	0.00135	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.49e-05	0.00134	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	1.46e-05	0.00131	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	1.45e-05	0.00131	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—DNMT3A—Crohn's disease	1.41e-05	0.00127	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—UBE2D1—Crohn's disease	1.38e-05	0.00124	CbGpPWpGaD
Betamethasone—Asthenia—Prednisone—Crohn's disease	1.37e-05	0.00043	CcSEcCtD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.37e-05	0.00123	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TAGAP—Crohn's disease	1.37e-05	0.00123	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—ALB—Crohn's disease	1.37e-05	0.00123	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	1.36e-05	0.00122	CbGpPWpGaD
Betamethasone—Pruritus—Prednisone—Crohn's disease	1.35e-05	0.000424	CcSEcCtD
Betamethasone—PTGS2—Spinal Cord Injury—TLR4—Crohn's disease	1.35e-05	0.00122	CbGpPWpGaD
Betamethasone—Diarrhoea—Prednisone—Crohn's disease	1.31e-05	0.00041	CcSEcCtD
Betamethasone—PTGS2—Spinal Cord Injury—ICAM1—Crohn's disease	1.3e-05	0.00117	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	1.27e-05	0.00114	CbGpPWpGaD
Betamethasone—Dizziness—Prednisone—Crohn's disease	1.27e-05	0.000396	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.26e-05	0.00113	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—CD4—Crohn's disease	1.25e-05	0.00112	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—IFNG—Crohn's disease	1.25e-05	0.00112	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—SMAD3—Crohn's disease	1.25e-05	0.00112	CbGpPWpGaD
Betamethasone—Vomiting—Prednisone—Crohn's disease	1.22e-05	0.000381	CcSEcCtD
Betamethasone—Rash—Prednisone—Crohn's disease	1.21e-05	0.000378	CcSEcCtD
Betamethasone—Dermatitis—Prednisone—Crohn's disease	1.21e-05	0.000377	CcSEcCtD
Betamethasone—Headache—Prednisone—Crohn's disease	1.2e-05	0.000375	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—RSPO3—Crohn's disease	1.2e-05	0.00108	CbGpPWpGaD
Betamethasone—Nausea—Prednisone—Crohn's disease	1.14e-05	0.000356	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—SEL1L—Crohn's disease	1.13e-05	0.00102	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	1.12e-05	0.00101	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—IL1B—Crohn's disease	1.11e-05	0.001	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.1e-05	0.00099	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PLA2G4F—Crohn's disease	1.07e-05	0.000965	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.07e-05	0.000959	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCR9—Crohn's disease	1.04e-05	0.000933	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—IL6—Crohn's disease	1.03e-05	0.000928	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	1.03e-05	0.000926	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—UBE2D1—Crohn's disease	1.01e-05	0.000905	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	9.99e-06	0.000898	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	9.86e-06	0.000887	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—SMAD3—Crohn's disease	9.84e-06	0.000886	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	9.68e-06	0.00087	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GPR65—Crohn's disease	9.64e-06	0.000867	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IFNG—Crohn's disease	9.64e-06	0.000867	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ZFP36L1—Crohn's disease	9.62e-06	0.000865	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—IL6—Crohn's disease	9.6e-06	0.000864	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—HSPA1B—Crohn's disease	9.56e-06	0.00086	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL1B—Crohn's disease	9.28e-06	0.000835	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	9.23e-06	0.00083	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	9.23e-06	0.00083	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	9.17e-06	0.000825	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—MTMR3—Crohn's disease	9.12e-06	0.000821	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—Crohn's disease	9.09e-06	0.000818	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—STAT3—Crohn's disease	9e-06	0.00081	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	8.96e-06	0.000806	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	8.8e-06	0.000791	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL1B—Crohn's disease	8.6e-06	0.000773	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—UBE2D1—Crohn's disease	8.38e-06	0.000754	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—DNMT3A—Crohn's disease	8.18e-06	0.000736	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	8.07e-06	0.000726	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—TNF—Crohn's disease	7.79e-06	0.000701	CbGpPWpGaD
Betamethasone—PTGS2—Disease—RSPO3—Crohn's disease	7.48e-06	0.000673	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—SMAD3—Crohn's disease	7.2e-06	0.000647	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PLA2G4F—Crohn's disease	7.17e-06	0.000645	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—FADS1—Crohn's disease	7.11e-06	0.000639	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SEL1L—Crohn's disease	7.09e-06	0.000638	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCR6—Crohn's disease	6.87e-06	0.000618	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—TNF—Crohn's disease	6.74e-06	0.000606	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GPX4—Crohn's disease	6.66e-06	0.000599	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	6.51e-06	0.000586	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.5e-06	0.000585	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GCKR—Crohn's disease	6.43e-06	0.000578	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	6.38e-06	0.000574	CbGpPWpGaD
Betamethasone—PTGS2—Disease—LTF—Crohn's disease	6.36e-06	0.000572	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—IL6—Crohn's disease	6.29e-06	0.000566	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—TNF—Crohn's disease	6.24e-06	0.000561	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RBX1—Crohn's disease	6.21e-06	0.000559	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—MTMR3—Crohn's disease	6.1e-06	0.000548	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTGER4—Crohn's disease	6.05e-06	0.000544	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—SMAD3—Crohn's disease	6e-06	0.000539	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.75e-06	0.000517	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—ALB—Crohn's disease	5.6e-06	0.000504	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—HSPA1B—Crohn's disease	5.52e-06	0.000497	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—UBE2D1—Crohn's disease	5.45e-06	0.00049	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL6—Crohn's disease	5.44e-06	0.000489	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RIPK2—Crohn's disease	5.28e-06	0.000475	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL3—Crohn's disease	5.15e-06	0.000463	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	5.15e-06	0.000463	CbGpPWpGaD
Betamethasone—PTGS2—Disease—GCKR—Crohn's disease	5.13e-06	0.000461	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PLA2G4F—Crohn's disease	5.08e-06	0.000457	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RASGRP1—Crohn's disease	4.98e-06	0.000448	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTGS2—Crohn's disease	4.9e-06	0.000441	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—UBE2D1—Crohn's disease	4.84e-06	0.000436	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—FADS1—Crohn's disease	4.75e-06	0.000427	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.59e-06	0.000413	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	4.56e-06	0.00041	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SLC11A1—Crohn's disease	4.53e-06	0.000408	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SOCS1—Crohn's disease	4.52e-06	0.000406	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GPX4—Crohn's disease	4.45e-06	0.0004	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	4.34e-06	0.000391	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—MTMR3—Crohn's disease	4.32e-06	0.000389	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GCKR—Crohn's disease	4.3e-06	0.000386	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.02e-06	0.000362	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SMAD3—Crohn's disease	3.9e-06	0.000351	CbGpPWpGaD
Betamethasone—PTGS2—Disease—RBX1—Crohn's disease	3.89e-06	0.00035	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HSPA1B—Crohn's disease	3.89e-06	0.00035	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL2RA—Crohn's disease	3.61e-06	0.000325	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—SMAD3—Crohn's disease	3.47e-06	0.000312	CbGpPWpGaD
Betamethasone—PTGS2—Disease—UBE2D1—Crohn's disease	3.41e-06	0.000307	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—FADS1—Crohn's disease	3.37e-06	0.000303	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GPX4—Crohn's disease	3.15e-06	0.000284	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	3.13e-06	0.000282	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	3.08e-06	0.000277	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.07e-06	0.000276	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GCKR—Crohn's disease	3.05e-06	0.000274	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MTMR3—Crohn's disease	2.66e-06	0.00024	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TYK2—Crohn's disease	2.54e-06	0.000229	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SMAD3—Crohn's disease	2.44e-06	0.000219	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—JAK2—Crohn's disease	2.43e-06	0.000218	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CXCL8—Crohn's disease	2.21e-06	0.000199	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—FADS1—Crohn's disease	2.07e-06	0.000187	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.07e-06	0.000186	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ALB—Crohn's disease	2.05e-06	0.000184	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GPX4—Crohn's disease	1.94e-06	0.000175	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GCKR—Crohn's disease	1.88e-06	0.000169	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTGS2—Crohn's disease	1.79e-06	0.000161	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—STAT3—Crohn's disease	1.78e-06	0.00016	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TYK2—Crohn's disease	1.59e-06	0.000143	CbGpPWpGaD
Betamethasone—PTGS2—Disease—JAK2—Crohn's disease	1.52e-06	0.000137	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CD4—Crohn's disease	1.44e-06	0.000129	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ALB—Crohn's disease	1.37e-06	0.000123	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6—Crohn's disease	1.24e-06	0.000112	CbGpPWpGaD
Betamethasone—PTGS2—Disease—STAT3—Crohn's disease	1.11e-06	0.0001	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ALB—Crohn's disease	9.69e-07	8.72e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGS2—Crohn's disease	8.48e-07	7.63e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6—Crohn's disease	7.78e-07	7e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ALB—Crohn's disease	5.97e-07	5.37e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTGS2—Crohn's disease	5.22e-07	4.7e-05	CbGpPWpGaD
